• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞因子微环境损害 HPV 阴性而非 HPV 阳性头颈部鳞状细胞癌中肿瘤浸润浆细胞样树突状细胞的功能能力。

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.

机构信息

, Sotio, Prague, Czech Republic.

Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic.

出版信息

Cancer Immunol Immunother. 2021 Sep;70(9):2545-2557. doi: 10.1007/s00262-021-02874-y. Epub 2021 Feb 11.

DOI:10.1007/s00262-021-02874-y
PMID:33569630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10992977/
Abstract

Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.

摘要

浆细胞样树突状细胞 (pDCs) 是最有效的 I 型干扰素产生细胞,在抗病毒免疫中发挥重要作用。研究表明,肿瘤浸润的 pDCs 主要具有促肿瘤生成作用,其产生干扰素 α (IFNα) 的能力降低,并通过 ICOS/ICOS-L 途径证实了其激活调节性 T 细胞 (Tregs) 的能力。由于相当数量的头颈鳞状细胞癌 (HNSCC) 是由人乳头瘤病毒诱导的,并且与非病毒诱导的肿瘤相比具有明显不同的免疫特征,因此我们比较了 HNSCC 浸润的 pDCs 的表型和功能能力与肿瘤的 HPV 状态。我们观察到 HPV 阴性样本中 TLR 激活后 pDC 产生 IFNα 的能力降低,而 HPV 相关肿瘤中 pDC 的功能相当未受影响。此外,来自非病毒诱导但非 HPV 相关肿瘤细胞悬浮液的上清液可显著抑制外周血来源的 pDC 产生 IFNα。我们确定了 IL-10 和 TNFα 作为可溶性 pDC 抑制因子,其在 HPV 阴性和 HPV 阳性肿瘤来源的上清液之间具有最高的可变性。此外,我们观察到 HPV 阴性样本中肿瘤浸润的 pDCs 与 Tregs 之间存在正相关,但在病毒诱导的肿瘤中则不存在。总的来说,我们的研究表明,富含 IL-10 和 TNFα 的免疫抑制细胞因子微环境在 HPV 阴性但不是 HPV 阳性的 HNSCC 中显著影响肿瘤浸润的 pDC 的功能能力,这种功能失调的 pDCs 可能通过促进肿瘤组织中 Tregs 的扩增进一步支持免疫抑制的肿瘤微环境。

相似文献

1
The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC.细胞因子微环境损害 HPV 阴性而非 HPV 阳性头颈部鳞状细胞癌中肿瘤浸润浆细胞样树突状细胞的功能能力。
Cancer Immunol Immunother. 2021 Sep;70(9):2545-2557. doi: 10.1007/s00262-021-02874-y. Epub 2021 Feb 11.
2
Assessment of pDCs functional capacity upon exposure to tumor-derived soluble factors.评估树突状细胞在暴露于肿瘤来源的可溶性因子后的功能能力。
Methods Cell Biol. 2024;189:85-96. doi: 10.1016/bs.mcb.2024.07.002. Epub 2024 Aug 23.
3
Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming.浆细胞样树突状细胞具有细胞因子产生能力,可在 T 细胞启动过程中增强 ICOSL 配体介导的 IL-10 产生。
Int Immunol. 2013 Mar;25(3):171-82. doi: 10.1093/intimm/dxs103. Epub 2012 Nov 2.
4
Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer.浆细胞样树突状细胞和诱导共刺激因子阳性调节性 T 细胞在胃癌免疫抑制微环境中的作用。
Cancer Sci. 2014 Feb;105(2):150-8. doi: 10.1111/cas.12327. Epub 2014 Jan 4.
5
HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.HMGB1 分泌在宫颈癌发生过程中促进浆细胞样树突状细胞获得免疫耐受功能。
Int J Cancer. 2015 Jul 15;137(2):345-58. doi: 10.1002/ijc.29389. Epub 2014 Dec 27.
6
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.头颈部肿瘤中肿瘤浸润浆细胞样树突状细胞的鉴定及功能分析
Cancer Res. 2003 Oct 1;63(19):6478-87.
7
Disruption of the Notch pathway aggravates airway inflammation by inhibiting regulatory T cell differentiation via regulation of plasmacytoid dendritic cells. Notch 通路的破坏通过调节浆细胞样树突状细胞抑制调节性 T 细胞分化,从而加重气道炎症。
Scand J Immunol. 2020 May;91(5):e12865. doi: 10.1111/sji.12865. Epub 2020 Mar 17.
8
Type I conventional dendritic cells and CD8 T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients.I 型传统树突状细胞和 CD8 T 细胞预测头颈部鳞状细胞癌患者的良好临床结局。
Front Immunol. 2024 Jun 13;15:1414298. doi: 10.3389/fimmu.2024.1414298. eCollection 2024.
9
Culture supernatants of oral cancer cells induce impaired IFN-α production of pDCs partly through the down-regulation of TLR-9 expression.口腔癌细胞的培养上清液部分通过下调 TLR-9 表达诱导 pDCs 产生受损的 IFN-α。
Arch Oral Biol. 2018 Sep;93:141-148. doi: 10.1016/j.archoralbio.2018.06.006. Epub 2018 Jun 5.
10
Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response.轮状病毒结构蛋白和双链 RNA 是诱导人原代浆细胞样树突状细胞 IFNα 反应所必需的。
PLoS Pathog. 2010 Jun 3;6(6):e1000931. doi: 10.1371/journal.ppat.1000931.

引用本文的文献

1
Molecular insights into immune evasion in head and neck squamous cell carcinomas: Toward a promising treatment strategy.头颈部鳞状细胞癌免疫逃逸的分子见解:迈向一种有前景的治疗策略。
Oncol Res. 2025 May 29;33(6):1271-1282. doi: 10.32604/or.2025.062207. eCollection 2025.
2
Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling.浆细胞样树突状细胞在抗肿瘤免疫的最前沿:重塑肿瘤微环境的重布线策略。
J Exp Clin Cancer Res. 2024 Jul 17;43(1):196. doi: 10.1186/s13046-024-03121-9.
3
Type I conventional dendritic cells and CD8 T cells predict favorable clinical outcome of head and neck squamous cell carcinoma patients.I 型传统树突状细胞和 CD8 T 细胞预测头颈部鳞状细胞癌患者的良好临床结局。
Front Immunol. 2024 Jun 13;15:1414298. doi: 10.3389/fimmu.2024.1414298. eCollection 2024.
4
In vitro Immunostimulant Activity of the Polyphenolic Extract from the Arctic Brown Algae Fucus vesiculosus.北极褐藻泡叶藻多酚提取物的体外免疫刺激活性。
Plant Foods Hum Nutr. 2024 Jun;79(2):511-517. doi: 10.1007/s11130-024-01174-x. Epub 2024 Apr 13.
5
Association between spatial distribution of leukocyte subsets and clinical presentation of head and neck squamous cell carcinoma.白细胞亚群的空间分布与头颈部鳞状细胞癌临床表现的相关性。
Front Immunol. 2024 Jan 23;14:1240394. doi: 10.3389/fimmu.2023.1240394. eCollection 2023.
6
Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity.浆细胞样树突状细胞相互作用在肿瘤免疫中的新作用。
Cancer Biol Med. 2023 Oct 9;20(10):728-47. doi: 10.20892/j.issn.2095-3941.2023.0241.
7
Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer.重塑肿瘤微环境以克服人乳头瘤病毒阴性头颈癌的治疗耐药性。
Cancer Drug Resist. 2023 May 30;6(2):291-313. doi: 10.20517/cdr.2022.141. eCollection 2023.
8
The interplay of cytokine signaling and non-coding RNAs in head and neck squamous cell carcinoma pathobiology.细胞因子信号与非编码 RNA 在头颈部鳞状细胞癌病理生物学中的相互作用。
Mol Biol Rep. 2022 Nov;49(11):10825-10847. doi: 10.1007/s11033-022-07770-x. Epub 2022 Jul 24.
9
The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications.人乳头瘤病毒阳性与阴性头颈癌的关键差异:生物学及临床意义
Cancers (Basel). 2021 Oct 17;13(20):5206. doi: 10.3390/cancers13205206.
10
Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.浆细胞样树突状细胞的 I 型干扰素产生受调控。
Int J Mol Sci. 2021 Apr 18;22(8):4190. doi: 10.3390/ijms22084190.

本文引用的文献

1
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 T cells.肿瘤浸润 B 细胞通过与 CD8 T 细胞的细胞间相互作用影响口咽鳞状细胞癌的进展。
J Immunother Cancer. 2019 Oct 17;7(1):261. doi: 10.1186/s40425-019-0726-6.
2
pDC depletion induced by CD317 blockade drives the antitumor immune response in head and neck squamous cell carcinoma.阻断 CD317 诱导的 pDC 耗竭可促进头颈部鳞状细胞癌的抗肿瘤免疫反应。
Oral Oncol. 2019 Sep;96:131-139. doi: 10.1016/j.oraloncology.2019.07.019. Epub 2019 Jul 26.
3
Immunology of Plasmacytoid Dendritic Cells in Solid Tumors: A Brief Review.实体瘤中浆细胞样树突状细胞的免疫学:简要综述
Cancers (Basel). 2019 Apr 3;11(4):470. doi: 10.3390/cancers11040470.
4
Toxicity Reduction in the Treatment of HPV Positive Oropharyngeal Cancer: Emerging Combined Modality Approaches.降低人乳头瘤病毒阳性口咽癌治疗中的毒性:新兴的联合治疗方法
Front Oncol. 2018 Oct 9;8:439. doi: 10.3389/fonc.2018.00439. eCollection 2018.
5
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.TIM-3 上调和调节性 T 细胞浸润介导放疗抵抗和 PD-L1 阻断。
Clin Cancer Res. 2018 Nov 1;24(21):5368-5380. doi: 10.1158/1078-0432.CCR-18-1038. Epub 2018 Jul 24.
6
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.帕博利珠单抗治疗复发性/转移性头颈部鳞状细胞癌的疗效和安全性:KEYNOTE-012 长期随访后的汇总分析。
Br J Cancer. 2018 Jul;119(2):153-159. doi: 10.1038/s41416-018-0131-9. Epub 2018 Jun 29.
7
IL-10 in the microenvironment of HNSCC inhibits the CpG ODN induced IFN-α secretion of pDCs.头颈部鳞状细胞癌微环境中的白细胞介素-10抑制CpG寡脱氧核苷酸诱导的浆细胞样树突状细胞分泌干扰素-α。
Oncol Lett. 2018 Mar;15(3):3985-3990. doi: 10.3892/ol.2018.7772. Epub 2018 Jan 11.
8
Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.肿瘤浸润性浆细胞样树突状细胞增多预示着口腔鳞状细胞癌预后不良。
Arch Oral Biol. 2017 Jun;78:129-134. doi: 10.1016/j.archoralbio.2017.02.012. Epub 2017 Feb 10.
9
Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.头颈部肿瘤—美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Mar;67(2):122-137. doi: 10.3322/caac.21389. Epub 2017 Jan 27.
10
The head and neck cancer immune landscape and its immunotherapeutic implications.头颈部癌的免疫景观及其免疫治疗意义。
JCI Insight. 2016 Oct 20;1(17):e89829. doi: 10.1172/jci.insight.89829.